Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Zuranolone for the Treatment of Adults With Major Depressive Disorder: A Randomized, Placebo-Controlled Phase 3 Trial.
Journal: The American journal of psychiatry
Published: May 03, 2023
Zuranolone in Major Depressive Disorder: Results From MOUNTAIN-A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.
Journal: The Journal of clinical psychiatry
Published: February 22, 2023
Effect of Zuranolone on Concurrent Anxiety and Insomnia Symptoms in Women With Postpartum Depression.
Journal: The Journal of clinical psychiatry
Published: February 01, 2023
Efficacy and safety of zuranolone co-initiated with an antidepressant in adults with major depressive disorder: results from the phase 3 CORAL study.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: January 30, 2023
Targeting the Arginine Vasopressin V1b Receptor System and Stress Response in Depression and Other Neuropsychiatric Disorders.
Journal: Neuropsychiatric disease and treatment
Published: December 27, 2022
Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: Pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program.
Journal: Journal of affective disorders
Published: May 09, 2022
Patient-reported health-related quality of life from a randomized, placebo-controlled phase 2 trial of zuranolone in adults with major depressive disorder.
Journal: Journal of affective disorders
Published: November 10, 2021
Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial.
Journal: JAMA psychiatry
Published: June 30, 2021
Comment on "Understanding the Clinical Effects and Mechanisms of Action of Neurosteroids".
Journal: The American journal of psychiatry
Published: June 22, 2021
A phase 1 double-blind, placebo-controlled study of zuranolone (SAGE-217) in a phase advance model of insomnia in healthy adults.
Journal: Human psychopharmacology
Published: June 17, 2021
Achieving clinical response in postpartum depression leads to improvement in health-related quality of life.
Journal: Current medical research and opinion
Published: March 15, 2021
Brexanolone in Postpartum Depression: Post Hoc Analyses to Help Inform Clinical Decision-Making.
Journal: Journal of women's health (2002)
Published: November 12, 2020
Last Updated: 09/26/2026